Department of Molecular Pathology,
Massachusetts General Hospital,
Department of Molecular Pathology, Massachusetts General Hospital
Jessica S. Blackburn has not added Biography.
If you are Jessica S. Blackburn and would like to personalize this page please email our Author Liaison for assistance.
RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis.
Cancer research Nov, 2007 | Pubmed ID: 18006830
Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis.
The American journal of pathology Dec, 2008 | Pubmed ID: 18988801
Wild-type versus mutant MMP-8 in melanoma: 'when you come to a fork in the road, take it'.
Pigment cell & melanoma research Jun, 2009 | Pubmed ID: 19397759
Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer.
Journal of autoimmunity Nov-Dec, 2009 | Pubmed ID: 19800199
High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia.
Blood Apr, 2010 | Pubmed ID: 20056790
aMAZe-ing tools for mosaic analysis in zebrafish.
Nature methods Mar, 2010 | Pubmed ID: 20195251
Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA).
Nature methods Jan, 2011 | Pubmed ID: 21151135
High-throughput imaging of adult fluorescent zebrafish with an LED fluorescence macroscope.
Nature protocols Feb, 2011 | Pubmed ID: 21293462
Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish.
Nature communications Jan, 2016 | Pubmed ID: 26790525
Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish.
The Journal of experimental medicine 05, 2016 | Pubmed ID: 27139488
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia.
Cancer discovery 11, 2017 | Pubmed ID: 28974511
Targeting phosphatases of regenerating liver (PRLs) in cancer.
Pharmacology & therapeutics 10, 2018 | Pubmed ID: 29859177
Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo.
Oncogenesis Jan, 2020 | Pubmed ID: 32001668
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).
Scientific reports May, 2021 | Pubmed ID: 33986418
Long-read sequencing of the zebrafish genome reorganizes genomic architecture.
BMC genomics Feb, 2022 | Pubmed ID: 35144548
Phosphatase and Pseudo-Phosphatase Functions of Phosphatase of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals In Vitro.
ACS omega Aug, 2023 | Pubmed ID: 37636930
Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Jan, 2024 | Pubmed ID: 38104416
Examining Phosphatases Through Immunofluorescent Microscopy.
Methods in molecular biology (Clifton, N.J.) , 2024 | Pubmed ID: 38147211
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유